ClinicalTrials.Veeva

Menu

VIsual Cerebral ConnecTivity On Functional Magnetic Resonance Imaging in Patients With Hereditary REtinal Dystrophies (VICTOIRE)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Enrolling

Conditions

Vision Functional Brain Networks in Patients With Hereditary Retinal Dystrophies

Treatments

Device: IRMf-r (séquence resting state)

Study type

Observational

Funder types

NETWORK

Identifiers

NCT04648124
ALR_2020_30

Details and patient eligibility

About

The Rothschild Foundation A Hospital follows a cohort of approximately 300 patients with hereditary retinal dystrophy. These patients are followed in ophthalmology consultation every year. In order to plan the MRI on the day of the annual consultation and to avoid additional travel for patients, patients will be informed of the study before the consultation (transmission of an information letter and the information note from study). If patients agree to participate in the study, rMRI will be scheduled. During the follow-up ophthalmologic consultation, after checking the inclusion and non-inclusion criteria, the study information will be repeated, and patients who still agree to participate will sign the study consent.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over 18 years old
  • Diagnostic clinique de dystrophie rétinienne héréditaire ou maculopathie héréditaire, syndromique ou non syndromique
  • Artificial vision treatment such as a retinal implant, or optogenetics scheduled in the next 6 months
  • Express consent to participate in the study
  • Affiliate or beneficiary of a social security scheme

Exclusion criteria

  • Patient benefiting from a legal protection measure
  • Pregnant or breastfeeding woman
  • Contraindication to MRI (claustrophobia, implanted equipment such as pacemaker).
  • Other additional ocular pathology that can significantly affect vision
  • Recent eye surgery less than 3 months old

Trial design

200 participants in 3 patient groups

Patients for whom there is no planned implant surgery
Treatment:
Device: IRMf-r (séquence resting state)
Patients for whom implantation surgery is planned
Treatment:
Device: IRMf-r (séquence resting state)
case
Treatment:
Device: IRMf-r (séquence resting state)

Trial contacts and locations

1

Loading...

Central trial contact

Amélie YAVCHITZ

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems